TITLE:
Effects of Teriparatide in Postmenopausal Women With Osteoporosis

CONDITION:
Postmenopausal Osteoporosis

INTERVENTION:
teriparatide

SUMMARY:

      Effects of Teriparatide in Postmenopausal Women Previously Treated with Alendronate or
      Raloxifene.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: Female
Age: 50 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Postmenopausal women aged at least 50 years

          -  A previous clinical diagnosis of osteoporosis

          -  At high risk for fracture

          -  Current therapy for at least 18 months prior to study entry with either raloxifene
             HCl or alendronate Na

        Exclusion Criteria:

          -  History of metabolic bone disease other than osteoporosis

          -  History of malignant neoplasm within the last 5 years except for superficial basal
             cell carcinoma or squamous cell carcinoma
      
